[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"law-gii-am-nutzenv":3},{"abbreviation":4,"title":5,"source_type":6,"total":7,"offset":8,"publishable_count":9,"is_thin":10,"entries":11},"am-nutzenv","Verordnung über die Nutzenbewertung von Arzneimitteln nach § 35a Absatz 1 SGB V für Erstattungsvereinbarungen nach § 130b SGB V","gii",12,0,11,false,[12,15,19,23,27,31,35,39,43,47,51,55],{"norm_key":13,"title":14,"chapter":14,"slug":14},"Eingangsformel",null,{"norm_key":16,"title":17,"chapter":14,"slug":18},"§ 1","Geltungsbereich","1",{"norm_key":20,"title":21,"chapter":14,"slug":22},"§ 2","Begriffsbestimmungen","2",{"norm_key":24,"title":25,"chapter":14,"slug":26},"§ 3","Anwendungsbereich der Nutzenbewertung nach § 35a SGB V","3",{"norm_key":28,"title":29,"chapter":14,"slug":30},"§ 4","Dossier des pharmazeutischen Unternehmers","4",{"norm_key":32,"title":33,"chapter":14,"slug":34},"§ 5","Zusatznutzen","5",{"norm_key":36,"title":37,"chapter":14,"slug":38},"§ 6","Zweckmäßige Vergleichstherapie","6",{"norm_key":40,"title":41,"chapter":14,"slug":42},"§ 7","Nutzenbewertung","7",{"norm_key":44,"title":45,"chapter":14,"slug":46},"§ 8","Beratung","8",{"norm_key":48,"title":49,"chapter":14,"slug":50},"§ 9","Offenlegung","9",{"norm_key":52,"title":53,"chapter":14,"slug":54},"§ 10","Übergangsregelungen","10",{"norm_key":56,"title":57,"chapter":14,"slug":58},"§ 11","Inkrafttreten","11"]